UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000024543 |
|---|---|
| Receipt number | R000028250 |
| Scientific Title | Effects of Preoperative Immunonutrition in Patients Undergoing major hepatobiliary resection |
| Date of disclosure of the study information | 2016/10/24 |
| Last modified on | 2016/10/25 11:50:52 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effects of Preoperative Immunonutrition in Patients Undergoing major hepatobiliary resection
Acronym
Effects of Preoperative Immunonutrition in Patients Undergoing major hepatobiliary resection
Scientific Title
Effects of Preoperative Immunonutrition in Patients Undergoing major hepatobiliary resection
Scientific Title:Acronym
Effects of Preoperative Immunonutrition in Patients Undergoing major hepatobiliary resection
Region
| Japan |
Condition
Condition
Bile Duct Cancer
Classification by specialty
| Hepato-biliary-pancreatic surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to determine whether preoperative immunonutrition is effective on infectious complication and Th1/Th2 differentiation in patients with major hepatobiliary resection.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Developmental phase
Phase IV
Assessment
Primary outcomes
postoperative infectious complication
Key secondary outcomes
plasma IL-6, CRP, Th1/Th2 balance, resolvin E1
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Medicine | Food |
Interventions/Control_1
Dietary Supplement: Oral IMPACT
oral supplement for 5 days(1L/day) before surgery of a formula enriched with arginine, omega-3 fatty acids, and RNA
Other Name: Oral IMPACT; Ajinomoto Pharma Co., Ltd, Tokyo, Japan
Interventions/Control_2
ordinary diet
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 80 | years-old | > |
Gender
Male and Female
Key inclusion criteria
hemihepatectomy with bile duct resection
Key exclusion criteria
ongoing infection
gastrointestinal obstruction
respiratory dysfunction
cardiac dysfunction
hepatic dysfunction
renal failure
history of recent immunosuppressive or immunological disease
preoperative evidence of widespread metastatic disease
Target sample size
40
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Katsunori Furukawa |
Organization
Chiba University
Division name
Department of General Surgery
Zip code
Address
1-8-1 inohana, chuo-ku, chiba city
TEL
043-222-7171
k-furukawa@umin.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Katsunori Furukawa |
Organization
Chiba University
Division name
Department of General Surgery
Zip code
Address
1-8-1 inohana, chuo-ku, chiba city
TEL
043-222-7171
Homepage URL
k-furukawa@umin.ac.jp
Sponsor or person
Institute
Chiba University
Department of General Surgery
Institute
Department
Personal name
Funding Source
Organization
Ministry of Education, Culture, Sports, Science and Technology
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
YES
Study ID_1
NCT01256047
Org. issuing International ID_1
ClinicalTrials.gov
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 10 | Month | 24 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
https://www.ncbi.nlm.nih.gov/pubmed/26965712
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2009 | Year | 02 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2009 | Year | 03 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2016 | Year | 10 | Month | 24 | Day |
Last modified on
| 2016 | Year | 10 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028250
